Filing Flows › Myomo (MYO) › Q1 2025
Myomo (MYO) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 7, 2025
Myomo (MYO) reported revenue of $9.8M for the first quarter 2025 (Q1 2025), +162% from a year earlier and -19% from the quarter before. Operating margin was -35.8%, net loss $3.5M (35.2% of revenue).
Myomo, Q1 2025: revenue $9.8M (+162% year over year), operating margin -35.8%, net loss $3.5M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.8M | -19% | +162% |
| Operating profit | −$3.5M | — | — |
| Net earnings | −$3.5M | — | — |
| Operating cash flow | −$2.7M | -180% | — |
What changed
Revenue was $9.8M in Q1 2025, up 162% year over year and down 19% from the previous quarter.
Gross margin was 67.2%, up 6.0 points from a year earlier. Operating costs exceeded revenue by $3.5M, an operating margin of -35.8%. Operating expenses grew 64% against revenue growth of 162%. The fastest-growing cost line was Research & development (+87%). The quarter ended with a net loss of $3.5M, wider than the previous quarter's $260K loss.
Operating cash flow was −$2.7M. Non-cash charges added back $158K of depreciation and $540K of share-based compensation. Capital expenditures of $671K exceeded it, leaving free cash flow of −$3.3M.
Questions
What was Myomo's revenue in the first quarter 2025?
Myomo (MYO) reported revenue of $9.8M for the first quarter 2025 (Q1 2025), +162% from a year earlier and -19% from the quarter before.
Was Myomo profitable in the first quarter 2025?
Operating loss was $3.5M (-35.8% of revenue) and net loss $3.5M.
Source: Myomo 10-Q on SEC EDGAR.